The combination of ipilimumab and nivolumab replaces the previous standard of care for the first-line treatment of patients with intermediate- and poor-risk metastatic clear-cell renal cancer, according to updated EAU guidelines.

News

In a recent study, researchers compared the effectiveness of chemotherapy plus radiotherapy vs chemotherapy alone in patients with locally advanced bladder cancer.

The National Comprehensive Cancer Network (NCCN) recently issued an updated version of their guidelines for varying histologies of kidney cancer.

Read More

Some health care services are rarely offered among older patients in the perioperative period for kidney cancer.

Read More

Genetic variants that predispose individuals to longer telomere length appear to be associated with an increased risk of renal-cell carcinoma.

Research in Review

Kidney-sparing surgery (KSS) and radical nephroureterecttomy (RNU) lead to similar survival for low-grade and noninvasive upper tract urothelial carcinoma (UTUC), according to a review published in European Urology. 

Read More

Certain patients with metastatic renal cell carcinoma can (RCC) safely undergo active surveillance before initiating systemic treatment, findings from a study published in The Lancet Oncology show.

Read More

Surgery may improve survival for patients who receive targeted therapies for metastatic renal cell cancer, according to a study by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (Boston, MA).

Read More

Patients with renal cell carcinoma may continue to benefit from treatment with nivolumab even after the disease has progressed, according a study published JAMA Oncology.

Read More

Subscribe to Kidney Cancer